The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 726.00
Bid: 724.00
Ask: 726.00
Change: -11.00 (-1.49%)
Spread: 2.00 (0.276%)
Open: 724.00
High: 742.00
Low: 722.00
Prev. Close: 737.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

29 Jul 2010 07:00

RNS Number : 1085Q
Acal PLC
29 July 2010
 



 

 

 

 

7.00 AM

29 July 2010

 

 

 

 

ACAL plc

("Acal" or "the Group")

 

First Interim Management Statement

 

Encouraging start to the year with Electronics orders up 42%

 

 

Acal plc, a specialist provider of technology products and services across Europe and South Africa, is today issuing its first Interim Management Statement for the year ending 31 March 2011, which covers the period 1 April 2010 to date. This statement is being issued to the Group's Annual General Meeting which is being held today.

 

The Board is pleased to report that, since the Group's preliminary results announcement on 2 June 2010, trading has improved further with Group underlying* sales for the first quarter increasing by around 20% year on year and orders, a measure of current demand, increasing by 29%.

 

The improvements are being driven by the Electronics division, which for the first quarter accounted for around 77% of Group sales, where underlying* sales increased by around 26% and orders by 42% year on year. The integration of BFi Optilas is proceeding to plan and remains on track to be complete by the end of the financial year.

 

In the non-Electronics businesses, underlying* sales for the quarter increased by 3% on the prior year and order levels were unchanged with margins continuing to be under pressure in the Supply Chain division.

 

There has been no significant change to the Group's financial position during the period.

 

There were no material events or transactions that impacted the Group during the period covered by this Interim Management Statement.

 

Nick Jefferies, Group Chief Executive commented:

 

"The year has started strongly, with orders and sales growth continuing to be robust. The increase in customer orders in the Electronics division, being 42% ahead of the prior year, is particularly encouraging.

 

We remain focused on tight operational management and the implementation of the BFi Optilas integration. Whilst we remain cautious as to the sustainability of the recovery into the second half, the Board remains confident that our specialisation strategy will continue to make good progress."

 

*Underlying is at constant exchange rate, including acquisitions on a like for like basis and excluding a large customer contract in Supply Chain exited at the end of the previous financial year.

 

For further information:-

 

Nick Jefferies ~ Group Chief Executive

Simon Gibbins ~ Group Finance Director

 

Chris Lane / Nicola Krafft ~ Cubitt Consulting

 

01483 544500

01483 544500

 

020 7367 5100

 

 

Notes to the Interim Management Statement

 

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules.

Notes to Editors:

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three Divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic products to industrial manufacturing and design companies. The Supply Chain Division supplies new and refurbished IT, EPOS and ATM spare parts to service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDRUSDBGGI
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.